SYK Stryker Corp

By Colin Kellaher

Microbot Medical Inc. shares surged more than 40% in premarket trading Monday after the medical-device company said it will work with larger peer Stryker Corp. in a bid to develop the world's first dedicated robotic procedural kits for use in certain neurovascular procedures.

Microbot, based in Hingham, Mass., said it the companies will integrate Microbot's Liberty robotic system with Stryker's neurovascular instruments

Microbot said it will also continue to develop the Liberty system independently for use in peripheral and coronary procedures.

Microbot shares, which closed Thursday at $5.42, were recently up 46% to $7.92 in premarket trading.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

December 27, 2021 08:01 ET (13:01 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.